Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05138510 · ClinicalTrials.gov registry record
Sexual Health in Breast Cancer Patients
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 93
- Enrollment target
NCT05138510: Completed study, sponsored by University of Colorado, Denver.
NCT05138510 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 93 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05138510 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 93 participants
- Enrollment target
Study Summary
In the present study, we propose a mixed methods approach to characterize and address the sexual health needs among women with breast cancer at the time of diagnosis and throughout treatment.
Primary Outcome
Determine changes in sexual well-being throughout the course of breast cancer treatment, pre- and post-implementation of developed educational materials using the Sexual Health Among Women Receiving Breast Cancer Treatment Survey
Interventions
- BEHAVIORAL Focus Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2025-10-23 |
What the finished NCT05138510 record still lists
NCT05138510 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 93 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Focus Group is the first listed.
NCT05138510 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05138510 about?
NCT05138510 is a clinical study titled "Sexual Health in Breast Cancer Patients". In the present study, we propose a mixed methods approach to characterize and address the sexual health needs among women with breast cancer at the time of diagnosis and throughout treatment.
What is the current status of trial NCT05138510?
This trial is currently completed. The enrollment target is 93 participants. The study started on 2020-12-01. Estimated completion is 2025-10-23.
What interventions are being tested in trial NCT05138510?
The interventions under investigation include: Focus Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05138510?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI